Tonghua Dongbao Pharmaceutical Stock Forecast for 2023 - 2025 - 2030

Updated on 05/03/2024

Stock Rating
18
Price Target
¥14.68
Consensus
Outperform
Upside
45.49%
Analysts
0
Stock Rating
18
Upside
45.49%
Analysts
0
Price Target
¥14.68

Tonghua Dongbao Pharmaceutical Stock Forecast and Price Target

If the average 2024 price target of ¥14.68 recently set by prominent experts for Tonghua Dongbao Pharmaceutical is met, there would be a potential upside of approximately 45.49% from the last closing price in May, 2024. The high estimate is ¥15.73, and the low is ¥14.00. If you want to invest in 600867 stock, you might also want to take a look at how its competitors are doing.

¥14.68

45.49% Upside

Buy
Buy

Tonghua Dongbao Pharmaceutical Fair Value Forecast for 2023 - 2025 - 2030

In the last two years, Tonghua Dongbao Pharmaceutical's Price has decreased by 100.00%, going from ¥9.45 to ¥0.00. In the next year, analysts believe that Fair Value will reach ¥13.67 – an increase of 100.00%. For the next seven years, experts predict that Tonghua Dongbao Pharmaceutical's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
¥13.67
2025 Fair Value Forecast
¥14.87
2026 Fair Value Forecast
¥16.28
2027 Fair Value Forecast
¥9.94
2028 Fair Value Forecast
¥11.50
2029 Fair Value Forecast
¥13.09
2030 Fair Value Forecast
¥14.75
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600276 Stock Forecast Jiangsu Hengrui Medicine Buy 15
¥46.16 Buy/Sell ¥56.49 16.98%
T14 Stock Forecast Tianjin Pharmaceutical Da Ren ... Outperform 18
$34.99 Buy/Sell $1.70 30.89%
600436 Stock Forecast Zhangzhou Pientzehuang Pharmac... Outperform 18
¥237.24 Buy/Sell ¥302.86 19.10%
000538 Stock Forecast Yunnan Baiyao Group Co.,Ltd Outperform 18
¥57.25 Buy/Sell ¥65.39 11.79%
1093 Stock Forecast CSPC Pharmaceutical Group Buy 18
HK$6.71 Buy/Sell HK$9.50 38.60%

Tonghua Dongbao Pharmaceutical Revenue Forecast for 2023 - 2025 - 2030

Tonghua Dongbao Pharmaceutical's Revenue has grown In the last three years, rising from ¥2.89B to ¥3.08B – a growth of 6.34%. In the next year, analysts believe that Revenue will reach ¥3.48B – an increase of 13.01%. For the next seven years, experts predict that Tonghua Dongbao Pharmaceutical's Revenue will grow at a rate of 15.39%.

2024 Rev Forecast
¥3.48B
2025 Rev Forecast
¥3.91B
2026 Rev Forecast
¥3.49B
2027 Rev Forecast
¥3.36B
2028 Rev Forecast
¥3.42B
2029 Rev Forecast
¥3.58B
2030 Rev Forecast
¥3.55B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
000999 Stock Forecast China Resources Sanjiu Medical... Buy 18
¥59.97 Buy/Sell ¥65.95 13.62%
600085 Stock Forecast Beijing Tongrentang Outperform 16
¥42.33 Buy/Sell ¥61.18 27.57%
600196 Stock Forecast Shanghai Fosun Pharmaceutical ... Outperform 16
¥23.67 Buy/Sell ¥33.57 20.83%

Tonghua Dongbao Pharmaceutical Dividend per Share Forecast for 2023 - 2025 - 2030

Tonghua Dongbao Pharmaceutical's Dividend per Share has seen impressive growth In the last three years, rising from ¥0.21 to ¥0.25 – a growth of 19.05%. For the following year, the 3 analysts predict that Tonghua Dongbao Pharmaceutical's Dividend per Share will drop by 12.00%, reaching ¥0.22. In 2030, the professionals' prediction is that 600867's Dividend per Share will decrease by 6.43%, reaching ¥0.23.

2024 DPS Forecast
¥0.22
2025 DPS Forecast
¥0.22
2026 DPS Forecast
¥0.24
2027 DPS Forecast
¥0.24
2028 DPS Forecast
¥0.24
2029 DPS Forecast
¥0.23
2030 DPS Forecast
¥0.23
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
002294 Stock Forecast Shenzhen Salubris Pharmaceutic... Buy 18
¥31.92 Buy/Sell ¥35.65 15.91%
600079 Stock Forecast Humanwell Healthcare (Group) Buy 0
¥20.25 Buy/Sell ¥32.49 -100.00%
000513 Stock Forecast Livzon Pharmaceutical Group Outperform 18
¥36.98 Buy/Sell ¥39.23 11.41%

Tonghua Dongbao Pharmaceutical Free Cash Flow Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600518 Stock Forecast Kangmei Pharmaceutical - 6
¥1.99 Buy/Sell ¥25.97 -100.00%
300146 Stock Forecast Byhealth Outperform 15
¥15.84 Buy/Sell ¥26.39 29.42%
002262 Stock Forecast Jiangsu Nhwa Pharmaceutical Co... Buy 18
¥25.01 Buy/Sell ¥31.34 23.95%

Tonghua Dongbao Pharmaceutical EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Tonghua Dongbao Pharmaceutical's EBITDA has grown, moving from ¥1.25B to ¥1.46B – an increase of 16.31%. In the next year, analysts predict that EBITDA will jump to ¥1.67B – up 14.58% from the current level. Looking ahead to seven years, experts forecast that EBITDA will grow by 31.16%.

2024 EBITDA Forecast
¥1.67B
2025 EBITDA Forecast
¥1.82B
2026 EBITDA Forecast
¥2.09B
2027 EBITDA Forecast
¥1.85B
2028 EBITDA Forecast
¥1.80B
2029 EBITDA Forecast
¥1.82B
2030 EBITDA Forecast
¥1.91B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
900904 Stock Forecast Shanghai Shenqi Pharmaceutical... - 13
$6.53 Buy/Sell $0.00 -100.00%
600062 Stock Forecast China Resources Double-Crane P... Buy 16
¥21.77 Buy/Sell ¥26.00 18.24%
600380 Stock Forecast Joincare Pharmaceutical Group ... Buy 18
¥11.61 Buy/Sell ¥14.72 26.79%

Tonghua Dongbao Pharmaceutical EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Tonghua Dongbao Pharmaceutical's EBIT has seen an increase, rising from ¥1.10B to ¥1.27B. This represents a growth of 15.62%. Analysts predict that Tonghua Dongbao Pharmaceutical's EBIT will increase in the upcoming year, reaching ¥1.48B. This would represent an increase of 16.59%. Over the next seven years, experts predict that Tonghua Dongbao Pharmaceutical's EBIT will grow at a rate of 36.36%.

2024 EBIT Forecast
¥1.48B
2025 EBIT Forecast
¥1.72B
2026 EBIT Forecast
¥1.89B
2027 EBIT Forecast
¥1.66B
2028 EBIT Forecast
¥1.61B
2029 EBIT Forecast
¥1.65B
2030 EBIT Forecast
¥1.73B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
002773 Stock Forecast Chengdu Kanghong Pharmaceutica... Buy 11
¥21.70 Buy/Sell ¥24.00 -100.00%
603858 Stock Forecast Shandong Buchang Pharmaceutica... - 18
¥16.85 Buy/Sell ¥0.00 -100.00%
000623 Stock Forecast Jilin Aodong Pharmaceutical Gr... Buy 16
¥15.28 Buy/Sell ¥0.00 48.36%

Tonghua Dongbao Pharmaceutical EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last two years, Tonghua Dongbao Pharmaceutical's EPS has decreased by 100.00%, going from ¥0.47 to ¥0.00. In the next year, analysts believe that EPS will reach ¥0.68 – an increase of 100.00%. For the next seven years, experts predict that Tonghua Dongbao Pharmaceutical's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
¥0.68
2025 EPS Forecast
¥0.74
2026 EPS Forecast
¥0.81
2027 EPS Forecast
¥0.49
2028 EPS Forecast
¥0.57
2029 EPS Forecast
¥0.65
2030 EPS Forecast
¥0.73
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600422 Stock Forecast KPC Pharmaceuticals,Inc Buy 18
¥22.72 Buy/Sell ¥28.00 10.08%
000766 Stock Forecast Tonghua Golden-Horse Pharmaceu... - 11
¥17.16 Buy/Sell ¥33.00 -100.00%
002019 Stock Forecast Yifan Pharmaceutical Buy 16
¥13.24 Buy/Sell ¥16.42 43.50%